LobbyingUnitypoint Health lobbying by quarter
Unitypoint Health's latest lobbying report covers Q2 2026, at $60K. The four quarters Q4 2025–Q3 2026 total $180K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Unitypoint Health
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $180K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $60K | 1 |
| Q1 2023 | $60K | 1 |
| Q2 2023 | $60K | 1 |
| Q3 2023 | $60K | 1 |
| Q4 2023 | $60K | 1 |
| Q1 2024 | $60K | 1 |
| Q2 2024 | $60K | 1 |
| Q3 2024 | $60K | 1 |
| Q4 2024 | $60K | 1 |
| Q1 2025 | $60K | 1 |
| Q2 2025 | $60K | 1 |
| Q3 2025 | $60K | 1 |
| Q4 2025 | $60K | 1 |
| Q1 2026 | $60K | 1 |
| Q2 2026 | $60K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$450K · 15 reports
- Medicare and Medicaid$450K · 15 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Centers For Medicare and Medicaid Services (CMS)15 reports
- Federal Communications Commission (FCC)15 reports
- Health & Human Services, Dept of (HHS)15 reports
- HOUSE OF REPRESENTATIVES15 reports
- Office of Management & Budget (OMB)15 reports
- SENATE15 reports
- Drug Enforcement Administration (DEA)14 reports
- Health Resources & Services Administration (HRSA)14 reports
- Substance Abuse & Mental Health Services Administration (SAMHSA)14 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseUnitypoint Health | $900K | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/02for Q2 | In-house | $60K |
| 05/04for Q1 | In-house | $60K |
| 02/11for Q4 2025 | In-house | $60K |
| 25/11/10for Q3 2025 | In-house | $60K |
| 25/07/01for Q2 2025 | In-house | $60K |
| 25/05/05for Q1 2025 | In-house | $60K |
| 25/01/10for Q4 2024 | In-house | $60K |
| 24/10/25for Q3 2024 | In-house | $60K |
| 24/07/12for Q2 2024 | In-house | $60K |
| 24/05/02for Q1 2024 | In-house | $60K |
| 24/01/02for Q4 2023 | In-house | $60K |
| 23/10/10for Q3 2023 | In-house | $60K |
| 23/07/21for Q2 2023 | In-house | $60K |
| 23/05/04for Q1 2023 | In-house | $60K |
| 23/01/26for Q4 2022 | In-house | $60K |